Equities
Health CareMedical Equipment and Services
  • Price (DKK)216.20
  • Today's Change-2.60 / -1.19%
  • Shares traded346.27k
  • 1 Year change-24.54%
  • Beta1.3964
Data delayed at least 15 minutes, as of Feb 06 2023 15:59 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Demant A/S, formerly William Demant Holding A/S, is a Denmark-based company engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The Company operates globally, through more than 90 subsidiaries and associates worldwide.

  • Revenue in DKK (TTM)18.66bn
  • Net income in DKK2.65bn
  • Incorporated1983
  • Employees18.13k
  • Location
    Demant A/SKongebakken 9SMOERUM 2765DenmarkDNK
  • Phone+45 39177300
  • Fax+45 39277900
  • Websitehttps://www.demant.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DEMANT:CPH since
announced
Transaction
value
Beijing Shengwang Yuanbo Trading Co LtdDeal completed04 Mar 202204 Mar 2022Deal completed-20.10%--
Data delayed at least 15 minutes, as of Feb 06 2023 15:59 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ossur hf4.95bn293.11m14.97bn3.87k51.123.3923.453.020.69210.692111.7310.430.55882.366.681,281,617.003.364.814.035.6161.1962.746.017.890.91447.480.43087.19-0.00264.79-33.57-5.916.26--
Elekta AB (publ)9.98bn540.49m18.87bn4.66k36.213.2815.391.892.162.1639.9123.890.59723.402.843,209,640.003.254.845.998.8637.1241.035.448.880.75584.650.384755.055.706.33-7.9755.9812.7119.14
Ambu A/S4.44bn93.00m23.03bn4.41k277.436.1559.985.180.37160.371617.5316.770.68611.926.151,007,938.001.445.081.726.2757.4760.062.097.080.932--0.302227.9410.7413.54-62.35-20.9428.54--
GN Store Nord A/S17.52bn670.00m26.03bn8.17k36.343.3711.811.495.225.22136.8056.290.71873.064.892,423,492.002.959.044.3812.2051.4258.314.1111.120.51925.590.691133.6317.2912.7740.2610.0914.206.15
Getinge AB18.51bn1.63bn41.66bn11.11k27.392.2714.772.259.159.15103.87110.280.58582.715.68--5.213.976.545.1847.4047.998.906.561.5725.030.160539.884.604.69-16.1317.85-7.3423.16
Demant A/S18.66bn2.65bn50.41bn18.13k19.046.42--2.7011.4910.3781.1234.060.73282.055.311,106,131.0010.429.0718.4914.7875.1675.2314.2211.960.587945.490.62120.0023.758.33140.5013.0711.99--
Coloplast A/S23.52bn4.63bn167.15bn14.69k38.8230.3729.637.1121.7521.75110.5527.800.91482.506.561,613,711.0018.0027.7328.5142.8768.6668.1219.6722.590.561212.580.789889.1816.237.77-2.474.3910.635.92
Data as of Feb 06 2023. Currency figures normalised to Demant A/S's reporting currency: Danish Krone DKK

Institutional shareholders

10.76%Per cent of shares held by top holders
HolderShares% Held
Canada Pension Plan Investment Boardas of 23 Aug 202111.77m5.11%
The Vanguard Group, Inc.as of 05 Jan 20232.59m1.13%
Norges Bank Investment Managementas of 31 Dec 20212.39m1.04%
Swedbank Robur Fonder ABas of 30 Dec 20222.09m0.91%
BlackRock Fund Advisorsas of 05 Jan 20231.33m0.58%
Nykredit Bank A/S (Investment Management)as of 31 Dec 20221.17m0.51%
Handelsbanken Fonder ABas of 31 Jan 2023930.67k0.40%
Nordea Investment Management AB (Denmark)as of 31 Dec 2022913.29k0.40%
Danske Bank A/S (Investment Management)as of 03 Feb 2023839.81k0.37%
BlackRock Advisors (UK) Ltd.as of 04 Jan 2023760.06k0.33%
More ▼
Data from 31 Dec 2021 - 03 Feb 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.